Acceleration of stiffness in underperfused diabetic rat hearts by glyburide, a K(ATP) channel blocker, and its prevention by levcromakalim and insulin

Cardiovascular Research

Volumn 35, Issue 2, 1997, Pages 303-314

  Higuchi, Makie ^a   Miyagi, Kanako ^a   Kayo, Susumu ^a   Sakanashi, Matao ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

ATP sensitive; Coronary flow; Diabetes mellitus; Energy metabolism; Glibenclamide; Insulin; Levcromakalim; Norepinephrine; Potassium channel; Potassium channel opener; Rat, heart; Sulfonylureas

Indexed keywords

GLIBENCLAMIDE; LEMAKALIM; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DRUG BINDING; DRUG MECHANISM; HEART PERFUSION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CORONARY CIRCULATION; CROMAKALIM; DIABETES MELLITUS, EXPERIMENTAL; GLYBURIDE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; PERFUSION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030829005     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00119-3     Document Type: Article

References (36)

1. + channels in cardiac muscle. Nature 1983;305:147-148.
2. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-581.
3. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
4. ATP channel. Am J Physiol 1994;266:H829-H839.
5. ATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am J Physiol 1996;271:H23-H28.
6. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19:789-815.
7. + currents in pancreatic β-cells. Naunyn-Schmiedeberg's Arch Pharmacol 1988;337:225-230.
8. + channels in cardiac muscle by the sulphonylurea drug glibenclamide. J Pharmacol Exp Ther 1992;261:540-545.
9. Smits P, Thien T. Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?. Diabetologia 1995;38:116-121.
10. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984;108:31-37.
11. Vered Z, Battler A, Segal P, et al. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 1984;54:633-637.
12. Higuchi M, Ikema S, Matsuzaki T, Hirayama K, Sakanashi M. Effects of norepinephrine on hypoperfusion-reperfusion injuries in hearts isolated from normal and diabetic rats. J Mol Cell Cardiol 1991;23:137-148.
13. Higuchi M, Ikema S, Sakanashi M. Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts. J Mol Cell Cardiol 1992;24:1125-1141.
14. Higuchi M, Uezu K, Sakanashi M. Ex vivo effect of insulin on normal and diabetic rat hearts hypoperfused with norepinephrine. Eur J Pharmacol 1993;242:293-300.
15. Higuchi M, Miyagi K, Nakasone J, Sakanashi M. Role of high glycogen in underperfused diabetic rat hearts with added norepinephrine. J Cardiovasc Pharmacol 1995;26:899-907.
16. + channels. J Biol Chem 1988;263:7933-7936.
17. + channels in isolated cardiac myocytes. Biochem Biophys Res Commun 1988;154:620-625.
18. + channel opening activity. Eur J Pharmacol 1993;245:165-171.
19. Jiang C, Mochizuki S, Poole-Wilson PA, Harding SE, MacLeod KT. Effects of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc Res 1994;28:851-857.
20. Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992;15:737-754.
21. Furchgott RE, DeGubareff T. The determination of inorganic phosphate and creatine phosphate in tissue extracts. J Biol Chem 1956;223:377-388.
22. Keppler D, Decker K. Glycogen. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 3rd edn. Weinheim: Verlag Chemie, 1984:11-18 (Metabolites 1: Carbohydrates; vol 6).
23. Keppler D, Decker K. Glycogen. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 3rd edn. Weinheim: Verlag Chemie, 1984:11-18 (Metabolites 1: Carbohydrates; vol 6).
24. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
25. Kowallik P, Schulz R, Guth BD, et al. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991;83:974-982.
26. Ehring T, Krajcar M, Baumgart D, Kompa S, Hummelgen M, Heusch G. Cholinergic and α-adrenergic coronary constriction with increasing ischemia-reperfusion injury. Am J Physiol 1995;268:H886-H894.
27. ATP channels in coronary vasodilation during exercise. Circulation 1993;88:1245-1253.
28. Nichols CG, Ripoll C, Lederer WJ. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 1991;68:280-287.
29. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 1990;259:H820-H826.
30. Milner P, Ralevic V, Hopwood AM, et al. Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 1989;45:121-125.
31. + channels involves high-energy phosphate preservation. Am J Physiol 1993;265:H1809-H1818.
32. Belloni FL, Hintze TH. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am J Physiol 1991;261:H720-H727.
33. Murakami M, Furukawa Y, Karasawa Y, Ren LM, Takayama S, Chiba S. Inhibition by glibenclamide of negative chronotropic and inotropic responses to pinacidil, acetylcholine, and adenosine in the isolated dog heart. J Cardiovasc Pharmacol 1992;19:618-624.
34. Higuchi M, Miyagi K, Sakanashi M. Non-diabetic than diabetic hearts with glyburide are more vulnerable to hypoperfusion with norepinephrine. J Mol Cell Cardiol 1995;27:A122.
35. Wolleben CD, Sanguinetti MC, Siegl PKS. Influence of ATP-sensitive pottasium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol 1989;21:783-788.
36. Morgan HE, Cadenas E, Regen DM, Park CR. Regulation of glucose uptake in muscle. II. Rate-limiting steps and effects of insulin and anoxia in heart muscle from diabetic rats. J Biol Chem 1961;236:262-268.